HMGB1 Promotes the Development of Pulmonary Arterial Hypertension in Rats
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference41 articles.
1. Humbert M, Sitbon O, Simonneau G (2004) Treatment of pulmonary arterial hypertension. N Engl J Med 351: 1425−36. PubMed: 15459304.
2. Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, et al.. (2004) Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 43: 25S−32S. PubMed: 15194175.
3. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, et al.. (2004) Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43: 13S−24S. PubMed: 15194174.
4. Wang W, Wang YL, Chen XY, Li YT, Hao W, Jin YP, et al.. (2011) Dexamethasone attenuates development of monocrotaline-induced pulmonary arterial hypertension. Mol Biol Rep 38: 3277−84. PubMed: 21431360.
5. Pullamsetti SS, Savai R, Janssen W, Dahal BK, Seeger W, Grimminger F, et al.. (2011) Inflammation, immunological reaction and role of infection in pulmonary hypertension. Clin Microbiol Infect 17: 7−14. PubMed: 20545963.
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. High Mobility Group Box 1 and Cardiovascular Diseases: Study of Act and Connect;Cardiovascular Toxicology;2024-09-06
2. The siRNA-mediated knockdown of AP-1 restores the function of the pulmonary artery and the right ventricle by reducing perivascular and interstitial fibrosis and key molecular players in cardiopulmonary disease;Journal of Translational Medicine;2024-02-05
3. The Effects of Sirna-mediated Knockdown of Ap-1 on Pulmonary Arterial and Right Ventricular Dysfunction Associated With Cardiac and Pulmonary Fibrosis in Cardiopulmonary Disease;2023-11-21
4. RNA ve protein seviyelerinde temel biyobelirteçleri belirlemek için pulmoner arteriyel hipertansiyonun in silico analizi;Düzce Üniversitesi Bilim ve Teknoloji Dergisi;2023-10-24
5. HMGB family proteins: Potential biomarkers and mechanistic factors in cardiovascular diseases;Biomedicine & Pharmacotherapy;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3